IMC Chicago’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-26,350
Closed -$975K 533
2022
Q3
$975K Buy
+26,350
New +$975K ﹤0.01% 108